The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. This year’s metric has recorded a Price increase of 199.05%. However, over the past six months, we’ve seen a weaker performance of 163.87%. The price of ACRS fallen by 163.87% over the last 30 days. And in the last five days, it has surged by 19.39%.
In terms of market performance, Aclaris Therapeutics Inc had a somewhat regular. The highest value for the stock in the past year was $2.72 on 11/18/24, while the lowest value was $0.77 on 11/27/23.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
52-week price history of ACRS Stock
A stock’s 52-week price history, including the low and high prices, can offer valuable insights into its current standing and future prospects. Aclaris Therapeutics Inc’s current trading price is 15.44% away from its 52-week high, while its distance from the 52-week low is 307.79%. The stock’s price range over this timeframe has been between $0.77 and $2.72. The shares of the Healthcare sector company recorded a trading volume of approximately 30.37 million for the day, which was comparatively higher than the average daily volume of 0.56 million over the last three months.
The Connection Between Financial Performance and Market Capitalization
Aclaris Therapeutics Inc (ACRS) has experienced a quarterly rise of 151.20% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 210.91M and boasts a workforce of 91 employees.
How Moving Averages and Trading Volume Data Work Together
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.39, with a change in price of +2.03. Similarly, Aclaris Therapeutics Inc recorded 1,040,206 in trading volume during the last 100 days, posting a change of +182.88%.
ACRS’s Debt-to-Equity Ratio: A Comprehensive Review
A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for ACRS stands at 0.02. Similarly, the long-term debt-to-equity ratio is also 0.02.
ACRS Stock Stochastic Average
Aclaris Therapeutics Inc’s raw stochastic average for the past 50 days is currently at 83.47%. This represents a surge from the raw stochastic average of the last 20 days, which was recorded at 82.83%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 68.26% and 72.01%, respectively.
